BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bautista-Becerril B, Pérez-Dimas G, Sommerhalder-Nava PC, Hanono A, Martínez-Cisneros JA, Zarate-Maldonado B, Muñoz-Soria E, Aquino-Gálvez A, Castillejos-López M, Juárez-Cisneros A, Lopez-Gonzalez JS, Camarena A. miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19. Viruses 2021;14:41. [PMID: 35062245 DOI: 10.3390/v14010041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Hardin LT, Xiao N. miRNAs: The Key Regulator of COVID-19 Disease. International Journal of Cell Biology 2022;2022:1-19. [DOI: 10.1155/2022/1645366] [Reference Citation Analysis]
2 Arisan ED, Dart DA, Grant GH, Dalby A, Kancagi DD, Turan RD, Yurtsever B, Karakus GS, Ovali E, Lange S, Uysal-onganer P. microRNA 1307 Is a Potential Target for SARS-CoV-2 Infection: An in Vitro Model. ACS Omega. [DOI: 10.1021/acsomega.2c05245] [Reference Citation Analysis]
3 Alvarez M, Trent E, Goncalves BDS, Pereira DG, Puri R, Frazier NA, Sodhi K, Pillai SS. Cognitive dysfunction associated with COVID-19: Prognostic role of circulating biomarkers and microRNAs. Front Aging Neurosci 2022;14:1020092. [DOI: 10.3389/fnagi.2022.1020092] [Reference Citation Analysis]
4 Yuan J, Feng Z, Wang Q, Han L, Guan S, Liu L, Ye H, Xu L, Han X. 3’UTR of SARS-CoV-2 spike gene hijack host miR-296 or miR-520h to disturb cell proliferation and cytokine signaling. Front Immunol 2022;13:924667. [DOI: 10.3389/fimmu.2022.924667] [Reference Citation Analysis]
5 Blann AD, Heitmar R. SARS-CoV-2 and COVID-19: A Narrative Review. Br J Biomed Sci 2022;79:10426. [DOI: 10.3389/bjbs.2022.10426] [Reference Citation Analysis]
6 Giannella A, Riccetti S, Sinigaglia A, Piubelli C, Razzaboni E, Di Battista P, Agostini M, Dal Molin E, Manganelli R, Gobbi F, Ceolotto G, Barzon L. Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients. Front Immunol 2022;13:968991. [DOI: 10.3389/fimmu.2022.968991] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Dias TR, Dias F, Teixeira AL, Sousa H, Oliveira J, Medeiros R. MicroRNAs as Potential Tools for Predicting Cancer Patients’ Susceptibility to SARS-CoV-2 Infection and Vaccination Response. Cells 2022;11:2279. [DOI: 10.3390/cells11152279] [Reference Citation Analysis]
8 Panda M, Kalita E, Singh S, Kumar K, Rao A, Prajapati VK. MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies. Life Sci 2022;:120761. [PMID: 35787998 DOI: 10.1016/j.lfs.2022.120761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Matusewicz L, Golec M, Czogalla A, Kuliczkowski K, Konka A, Zembala-John J, Sikorski AF. COVID-19 therapies: do we see substantial progress? Cell Mol Biol Lett 2022;27:42. [PMID: 35641916 DOI: 10.1186/s11658-022-00341-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]